Genmab A/S (GMAB) Financials

GMAB Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 5.2 billion 544.7 million
2023-09-30 5.0 billion 585.0 million
2023-06-30 4.7 billion 470.8 million
2023-03-31 4.4 billion 469.1 million

GMAB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 237.6 million ?
2023-09-30 274.9 million 23.0 million
2023-06-30 48.1 million 22.8 million
2023-03-31 458.4 million 16.8 million

GMAB Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 94.7 million
2023-09-30 383.1 million
2023-06-30 251.7 million
2023-03-31 41.9 million

GMAB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 4.2 billion - 114.0 million
2023-09-30 3.9 billion - 112.4 million
2023-06-30 3.6 billion - 117.3 million
2023-03-31 3.6 billion - 121.4 million

GMAB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 9.8 million
2023-09-30 93.4 million
2023-06-30 96.2 million
2023-03-31 96.6 million

GMAB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 9.9 million 288.4 million 138.3 million -
2023-09-30 13.9 million 296.1 million 119.0 million -
2023-06-30 15.6 million 270.7 million 123.9 million -
2023-03-31 15.2 million 254.9 million 99.0 million -

GMAB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 692.6 million 18.7 million
2023-09-30 672.6 million 14.2 million
2023-06-30 613.3 million -
2023-03-31 417.8 million -

GMAB

Price: $30.26

52 week price:
26.32
42.72

Earnings Per Share: 1.20 USD

P/E Ratio: 29.54

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 221594

Market Capitalization: 18.6 billion

Links: